Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer R Abduljabbar, OH Negm, CF Lai, DA Jerjees, M Al-Kaabi, MR Hamed, ... Breast cancer research and treatment 150 (2), 335-346, 2015 | 101 | 2015 |
Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not … AW Tarr, RA Urbanowicz, MR Hamed, A Albecka, CP McClure, ... Journal of virology 85 (9), 4246-4257, 2011 | 69 | 2011 |
Recombinant human L-ficolin directly neutralizes hepatitis C virus entry MR Hamed, RJP Brown, C Zothner, RA Urbanowicz, CP Mason, A Krarup, ... Journal of innate immunity 6 (5), 676-684, 2014 | 35 | 2014 |
Development and Validation of Protein Microarray Technology for Simultaneous Inflammatory Mediator Detection in Human Sera S Selvarajah, OH Negm, MR Hamed, C Tubby, I Todd, PJ Tighe, ... Mediators of inflammation 2014, 2014 | 34 | 2014 |
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers DAJ Ahmad, OH Negm, ML Alabdullah, S Mirza, MR Hamed, V Band, ... Breast Cancer Research and Treatment 159 (3), 457-467, 2016 | 32 | 2016 |
Human Blood Autoantibodies in the Detection of Colorectal Cancer OH Negm, MR Hamed, RE Schoen, RL Whelan, RJ Steele, J Scholefield, ... PLoS One 11 (7), e0156971, 2016 | 27 | 2016 |
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration OH Negm, B MacKenzie, MR Hamed, OAJ Ahmad, CC Shone, ... Clinical & Experimental Immunology 188 (3), 437-443, 2017 | 23 | 2017 |
Clinical utility of Reverse Phase Protein Array for Molecular Classification of Breast Cancer EARARG 7. Ola H. Negm, Abir A. Muftah, Mohammed A. Aleskandarany, Mohamed R ... Breast Cancer Res Treat, 2016 | 17* | 2016 |
Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis OH Negm, MR Hamed, EM Dilnot, CC Shone, I Marszalowska, M Lynch, ... Clinical and Vaccine Immunology 22 (9), 1033-1039, 2015 | 16 | 2015 |
High Prevalence of Subclass-Specific Binding and Neutralising Antibodies Against Clostridium Difficile Toxins in Adult Cystic Fibrosis Sera: Possible Mode of Protection Against … T Monaghan, O Negm, B MacKenzie, M Hamed, C Shone, DP Humphreys, ... Gastroenterology 152 (5), S344, 2017 | 12 | 2017 |
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection … TM Monaghan, OH Negm, B MacKenzie, MR Hamed, CC Shone, ... Clinical and experimental gastroenterology 10, 169, 2017 | 12 | 2017 |
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways DA Jerjees, OH Negm, ML Alabdullah, S Mirza, M Alkaabi, MR Hameed, ... Breast cancer research and treatment 150 (1), 91-103, 2015 | 12 | 2015 |
Patients with tumour necrosis factor (TNF) receptor‐associated periodic syndrome (TRAPS) are hypersensitive to Toll‐like receptor 9 stimulation OH Negm, S Singh, W Abduljabbar, MR Hamed, P Radford, ... Clinical & Experimental Immunology 197 (3), 352-360, 2019 | 10 | 2019 |
Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies AW Tarr, M Backx, MR Hamed, RA Urbanowicz, CP McClure, RJP Brown, ... Antiviral research, 2018 | 10 | 2018 |
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti‐E1E2) with HCV disease MRB Hamed, AW Tarr, CP McClure, JK Ball, TP Hickling, WL Irving Journal of viral hepatitis 15 (5), 339-345, 2008 | 10 | 2008 |
A signalome screening approach in the autoinflammatory disease TNF Receptor Associated Periodic Syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for … I Todd, OH Negm, J Reps, P Radford, G Figueredo, EM McDermott, ... Pharmacological research 125, 188-200, 2017 | 7 | 2017 |
A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection OH Negm, MR Hamed, TM Monaghan Journal of Visualized Experiments, 2018 | 4 | 2018 |
OC-058 A protein microarray assay for predicting severe outcomes in clostridium difficile infection TM Monaghan, T Jilani, M Hamed, O Ahmad, B MacKenzie, ... Gut 66 (Suppl 2), A31-A31, 2017 | 1 | 2017 |
Validation of an autoantibody blood test for the detection of early breast cancer (BC), particularly hormone receptor positive BC OH Negm, O Ahmed, GP Figueredo, MR Hamed, L Pollard, J Garibaldi, ... CANCER RESEARCH 78 (4), 2018 | | 2018 |
PWE-017 High prevalence of subclass-specific binding and neutralising antibodies against clostridium difficile toxins in adult cystic fibrosis sera: possible mode of protection … TM Monaghan, O Negm, B MacKenzie, M Hamed, CC Shone, ... Gut 66 (Suppl 2), A133-A135, 2017 | | 2017 |